UnitedHealth’s shares rose by 2% after receiving a price target boost from analyst Lance Wilkes, who raised the fair value assessment to $444 per share, maintaining an outperform recommendation. Wilkes expects UnitedHealth to surpass its 10% annual revenue growth with a 12% improvement in 2026. Despite past struggles, UnitedHealth remains a strong player in the health insurance sector, with potential upside in the coming months. While not on the list of top 10 stocks to buy now, it remains a solid investment option.

Read more at Nasdaq: Why UnitedHealth Stock Bumped Higher Today